We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAR:NASDAQMarriott International Analysis

Data as of 2026-04-16 - not real-time

$363.74

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Marriott (MAR) is trading at $363.74, comfortably above its 20‑day SMA (335.72) and 200‑day SMA (296.42), with the RSI at 68 indicating near‑overbought conditions. The MACD remains bullish (line 8.44 vs signal 4.10) but volume is decreasing and the overall trend is neutral, placing the stock just below its resistance at $367.32 and above a solid support of $316.54. Fundamentals show robust operating margins (44%), a healthy profit margin (37%), and 6.3% revenue growth, yet the DCF fair value of $49.07 and a forward PE of 28 suggest the market is pricing in significant premium. The dividend yield of 0.74% with a 28% payout ratio appears sustainable given strong operating cash flow, but the balance sheet reflects high debt ($17.2 B) and a negative book value per share. Analyst consensus is a “Buy” with a median target of $356, implying limited upside from current levels.
The stock’s valuation is clearly stretched, and short‑term momentum may face pressure near resistance, while medium‑term fundamentals support a re‑entry point if a correction occurs. Risks stem from the cyclical travel sector, elevated volatility (≈29% 30‑day) and a beta above 1, yet Marriott’s global brand strength and dividend track record provide a defensive cushion for longer horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI near overbought level
  • Proximity to technical resistance at $367.32
  • Decreasing volume trend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong operating and profit margins
  • Sustainable dividend with low payout ratio
  • Potential price correction providing entry below current level

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Global brand portfolio and loyalty program
  • Cyclical exposure to travel demand
  • Solid cash flow generation despite high debt

Key Metrics & Analysis

Financial Health

Revenue Growth6.30%
Profit Margin37.25%
P/E Ratio38.3
ROA9.63%
P/B Ratio-25.6
Op. Cash Flow$3.2B
Free Cash Flow$1.7B

Technical Analysis

TrendNeutral
RSI67.8
Support$316.54
Resistance$367.32
MA 20$335.72
MA 50$336.68
MA 200$296.42
MACDBullish
VolumeDecreasing
Fear & Greed Index88.98

Valuation

Fair Value$49.07
Target Price$357.32
Upside/Downside-1.76%
GradeOvervalued
TypeGrowth
Dividend Yield0.74%

Risk Assessment

Beta1.11
Volatility29.47%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.